Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/hiv-therapy-tweak-23615/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/hiv-therapy-tweak-23615/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/hiv-therapy-tweak-23615/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/hiv-therapy-tweak-23615/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-trace').style.display = (document.getElementById('cakeErr67f5ded963e63-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5ded963e63-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-code').style.display = (document.getElementById('cakeErr67f5ded963e63-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-context').style.display = (document.getElementById('cakeErr67f5ded963e63-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5ded963e63-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f5ded963e63-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 23451,
		&#039;title&#039; =&gt; &#039;HIV therapy tweak&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;hiv-therapy-tweak-23615&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 23615,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 23451,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | HIV therapy tweak&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;HIV AIDS,Health,Public Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.


The National AIDS Control Organisation...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 23451,
	&#039;title&#039; =&gt; &#039;HIV therapy tweak&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;hiv-therapy-tweak-23615&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 23615,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 23451
$metaTitle = &#039;LATEST NEWS UPDATES | HIV therapy tweak&#039;
$metaKeywords = &#039;HIV AIDS,Health,Public Health,medicines&#039;
$metaDesc = &#039;
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.


The National AIDS Control Organisation...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/hiv-therapy-tweak-23615.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | HIV therapy tweak | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.


The National AIDS Control Organisation..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>HIV therapy tweak</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.</p><p align="justify">The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.</p><p align="justify">Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.</p><p align="justify">&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.</p><p align="justify">The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.</p><p align="justify">Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.</p><p align="justify">He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.</p><p align="justify">Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.</p><p align="justify">Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-trace').style.display = (document.getElementById('cakeErr67f5ded963e63-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5ded963e63-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-code').style.display = (document.getElementById('cakeErr67f5ded963e63-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-context').style.display = (document.getElementById('cakeErr67f5ded963e63-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5ded963e63-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f5ded963e63-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 23451,
		&#039;title&#039; =&gt; &#039;HIV therapy tweak&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;hiv-therapy-tweak-23615&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 23615,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 23451,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | HIV therapy tweak&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;HIV AIDS,Health,Public Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.


The National AIDS Control Organisation...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 23451,
	&#039;title&#039; =&gt; &#039;HIV therapy tweak&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;hiv-therapy-tweak-23615&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 23615,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 23451
$metaTitle = &#039;LATEST NEWS UPDATES | HIV therapy tweak&#039;
$metaKeywords = &#039;HIV AIDS,Health,Public Health,medicines&#039;
$metaDesc = &#039;
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.


The National AIDS Control Organisation...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/hiv-therapy-tweak-23615.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | HIV therapy tweak | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.


The National AIDS Control Organisation..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>HIV therapy tweak</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.</p><p align="justify">The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.</p><p align="justify">Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.</p><p align="justify">&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.</p><p align="justify">The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.</p><p align="justify">Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.</p><p align="justify">He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.</p><p align="justify">Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.</p><p align="justify">Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-trace').style.display = (document.getElementById('cakeErr67f5ded963e63-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5ded963e63-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-code').style.display = (document.getElementById('cakeErr67f5ded963e63-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5ded963e63-context').style.display = (document.getElementById('cakeErr67f5ded963e63-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5ded963e63-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f5ded963e63-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 23451,
		&#039;title&#039; =&gt; &#039;HIV therapy tweak&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;hiv-therapy-tweak-23615&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 23615,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 23451,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | HIV therapy tweak&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;HIV AIDS,Health,Public Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.


The National AIDS Control Organisation...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 23451,
	&#039;title&#039; =&gt; &#039;HIV therapy tweak&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;hiv-therapy-tweak-23615&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 23615,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 23451
$metaTitle = &#039;LATEST NEWS UPDATES | HIV therapy tweak&#039;
$metaKeywords = &#039;HIV AIDS,Health,Public Health,medicines&#039;
$metaDesc = &#039;
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.


The National AIDS Control Organisation...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;New Delhi: &lt;/em&gt;People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India&#039;s national AIDS control programme.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;quot;We&#039;ve initiated the process for procuring more drugs - we&#039;ll begin to implement the new policy in about six to eight months,&amp;quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &amp;quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they&#039;re infected to seek treatment,&amp;quot; Rewari said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Senior Naco officials said the agency was working with institutions to drive an &amp;quot;employer-led-model&amp;quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don&#039;t work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/hiv-therapy-tweak-23615.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | HIV therapy tweak | Im4change.org</title>
    <meta name="description" content="
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.


The National AIDS Control Organisation..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>HIV therapy tweak</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.</p><p align="justify">The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.</p><p align="justify">Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.</p><p align="justify">&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.</p><p align="justify">The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.</p><p align="justify">Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.</p><p align="justify">He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.</p><p align="justify">Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.</p><p align="justify">Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 23451,
		'title' => 'HIV therapy tweak',
		'subheading' => '',
		'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<br />
<em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.
</p>
<p align="justify">
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
</p>
<p align="justify">
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
</p>
<p align="justify">
&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
</p>
<p align="justify">
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
</p>
<p align="justify">
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.
</p>
<p align="justify">
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
</p>
<p align="justify">
Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
</p>
<p align="justify">
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
</p>',
		'credit_writer' => 'The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'hiv-therapy-tweak-23615',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 23615,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 23451,
	'metaTitle' => 'LATEST NEWS UPDATES | HIV therapy tweak',
	'metaKeywords' => 'HIV AIDS,Health,Public Health,medicines',
	'metaDesc' => '
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.


The National AIDS Control Organisation...',
	'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.</p><p align="justify">The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.</p><p align="justify">Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.</p><p align="justify">&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.</p><p align="justify">The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.</p><p align="justify">Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.</p><p align="justify">He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.</p><p align="justify">Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.</p><p align="justify">Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 23451,
	'title' => 'HIV therapy tweak',
	'subheading' => '',
	'description' => '<div align="justify">
-The Telegraph
</div>
<p align="justify">
<br />
<em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.
</p>
<p align="justify">
The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.
</p>
<p align="justify">
Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.
</p>
<p align="justify">
&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.
</p>
<p align="justify">
The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.
</p>
<p align="justify">
Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.
</p>
<p align="justify">
He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.
</p>
<p align="justify">
Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.
</p>
<p align="justify">
Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.
</p>',
	'credit_writer' => 'The Telegraph, 11 December, 2013, http://www.telegraphindia.com/1131211/jsp/nation/story_17667811.jsp#.UqizKCe5ztA',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'hiv-therapy-tweak-23615',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 23615,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 23451
$metaTitle = 'LATEST NEWS UPDATES | HIV therapy tweak'
$metaKeywords = 'HIV AIDS,Health,Public Health,medicines'
$metaDesc = '
-The Telegraph



New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.


The National AIDS Control Organisation...'
$disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme.</p><p align="justify">The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below.</p><p align="justify">Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet.</p><p align="justify">&quot;We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months,&quot; said Bharat Bhushan Rewari, a physician and national programme official with Naco.</p><p align="justify">The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus.</p><p align="justify">Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. &quot;But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment,&quot; Rewari said.</p><p align="justify">He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200.</p><p align="justify">Senior Naco officials said the agency was working with institutions to drive an &quot;employer-led-model&quot; of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy.</p><p align="justify">Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

HIV therapy tweak

-The Telegraph New Delhi: People infected with the human immunodeficiency virus (HIV) across India will receive free anti-HIV therapy even while their immune systems are still strong under new guidelines adopted by India's national AIDS control programme. The National AIDS Control Organisation (Naco) will provide anti-HIV therapy when the number of a class of white blood cells called CD4 drops to 500 cells per cubic mm or lower, senior Naco officials said. Current guidelines call for therapy when CD4 drop to 350 or below. Naco already provides free anti-HIV therapy to about 7.1 lakh patients in India. The new guidelines, in line with recommendations from the World Health Organisation (WHO) earlier this year, will require the government to provide anti-HIV therapy to an additional 1 lakh patients. While not a cure, the anti-HIV therapy keeps HIV loads low and prevents the catastrophic collapse of the immune system as CD4 levels plummet. "We've initiated the process for procuring more drugs - we'll begin to implement the new policy in about six to eight months," said Bharat Bhushan Rewari, a physician and national programme official with Naco. The WHO had said earlier this year that its recommendation for anti-HIV therapy at CD4 levels of 500 is based on evidence that treating people with HIV early can keep them healthy and lower the amount of virus in their blood and reduce the risk of passing the virus. Naco estimates that about 2.1 million people in India are infected with HIV, and about half of them require anti-HIV therapy. "But about 30 per cent of people living with HIV remain unaware of their infection. Patients need to know they're infected to seek treatment," Rewari said. He added HIV-infected people who receive treatment have average survival periods of about 15 years, while those who do not get treatment will die from opportunistic infections within about two years after their CD4 levels drop below 200. Senior Naco officials said the agency was working with institutions to drive an "employer-led-model" of advocacy and testing, which will get companies to encourage their workers to test themselves for HIV and seek the therapy. Health activists have been urging the government to make available free third-line anti-HIV drugs required by patients for whom the first-line and second-line drugs don't work. But a senior official pointed out that the third-line drugs cost about Rs 15,000 per person per month, in contrast to Rs 5,500 per person per year for first-line drugs, and Rs 15,000 per person per year for second-line drugs.